CHECKMATE PHARMACEUTICALS IN (CMPI)

US1628181083 - Common Stock

10.5  +0.02 (+0.19%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-3-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
N/A0.000.000.000.00
Operating Expenses
63.17M61.47M37.00M28.89M20.99M
Research and Development
47.10M45.82M26.72M24.25M18.17M
Selling, General, and Administrative Expenses
16.08M15.65M10.29M4.64M2.82M
Operating Income
-63.17M-61.47M-37.00M-28.89M-20.99M
Interest Income/Expense
30.00K70.00K180.00K200.00K180.00K
Other Income/Expense
N/A0.00-80.00K400.00K0.00
Income Before Taxes
-63.15M-61.41M-36.91M-28.29M-20.81M
Net Income
-63.15M-61.41M-36.91M-28.29M-20.81M
EBITDA
N/A-61.40MN/AN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-2.92-2.84-1.71-1.32-0.97
Non GAAP EPS
-2.92-2.84N/AN/AN/A
 
Statistics

All data in USD

Charts